Tauns Laboratories (TSE:197A) Beneish M-Score: -3.10 (As of Jul. 18, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:197A Tauns Laboratories Inc TSE:197A
14 GF Score
Price 円484.00
! 6 Warning Signs
View Full Analysis

What is Tauns Laboratories Beneish M-Score?

Tauns Laboratories TSE:197A -0.82% 14 Beneish M-Score is -3.10 as of Jul. 18, 2026. GuruFocus rates TSE:197A with a GF Score™ of 14/100. The stock has 6 warning signs investors should review. Among 763 Medical Devices & Instruments companies, Tauns Laboratories ranks better than 80.47% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -3.1 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Tauns Laboratories's Beneish M-Score or its related term are showing as below:

TSE:197A' s Beneish M-Score Range Over the Past 10 Years
Min: -3.35   Med: -3.23   Max: -3.1
Current: -3.1

During the past 4 years, the highest Beneish M-Score of Tauns Laboratories was -3.10. The lowest was -3.35. And the median was -3.23.


Tauns Laboratories Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Tauns Laboratories's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tauns Laboratories Beneish M-Score Chart

Tauns Laboratories Annual Data
Trend Jun22 Jun23 Jun24 Jun25
Beneish M-Score
0.00 0.00 -3.35 -3.10

Tauns Laboratories Quarterly Data
Jun22 Jun23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -3.10 0.00 0.00 0.00

TSE:197A vs ISRG, BDX, MDLN: Beneish M-Score Comparison

For the Medical Instruments & Supplies subindustry, Tauns Laboratories's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tauns Laboratories Beneish M-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Tauns Laboratories's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Tauns Laboratories's Beneish M-Score falls into.


TSE:197A
14GF Score
Tauns Laboratories Inc TSE:197A
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tauns Laboratories Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Tauns Laboratories for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.0906+0.528 * 0.9886+0.404 * 1.5808+0.892 * 1.0105+0.115 * 1.4312
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0323+4.679 * -0.013777-0.327 * 0.9942
=-3.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun25) TTM:Last Year (Jun24) TTM:
Total Receivables was 円248 Mil.
Revenue was 円18,628 Mil.
Gross Profit was 円12,775 Mil.
Total Current Assets was 円15,477 Mil.
Total Assets was 円36,515 Mil.
Property, Plant and Equipment(Net PPE) was 円12,279 Mil.
Depreciation, Depletion and Amortization(DDA) was 円715 Mil.
Selling, General, & Admin. Expense(SGA) was 円2,635 Mil.
Total Current Liabilities was 円9,530 Mil.
Long-Term Debt & Capital Lease Obligation was 円8,809 Mil.
Net Income was 円6,315 Mil.
Gross Profit was 円0 Mil.
Cash Flow from Operations was 円6,818 Mil.
Total Receivables was 円2,707 Mil.
Revenue was 円18,435 Mil.
Gross Profit was 円12,498 Mil.
Total Current Assets was 円16,916 Mil.
Total Assets was 円29,261 Mil.
Property, Plant and Equipment(Net PPE) was 円7,905 Mil.
Depreciation, Depletion and Amortization(DDA) was 円676 Mil.
Selling, General, & Admin. Expense(SGA) was 円2,526 Mil.
Total Current Liabilities was 円10,474 Mil.
Long-Term Debt & Capital Lease Obligation was 円4,307 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(247.777 / 18627.99) / (2706.864 / 18434.863)
=0.013301 / 0.146834
=0.0906

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(12498.332 / 18434.863) / (12774.997 / 18627.99)
=0.677973 / 0.685796
=0.9886

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (15476.605 + 12279.213) / 36515.294) / (1 - (16915.714 + 7905.227) / 29261.325)
=0.239885 / 0.151749
=1.5808

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=18627.99 / 18434.863
=1.0105

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(676.163 / (676.163 + 7905.227)) / (715.426 / (715.426 + 12279.213))
=0.078794 / 0.055055
=1.4312

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(2634.78 / 18627.99) / (2525.771 / 18434.863)
=0.141442 / 0.137011
=1.0323

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((8809.081 + 9529.874) / 36515.294) / ((4307 + 10474.442) / 29261.325)
=0.502227 / 0.505153
=0.9942

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(6315.407 - 0 - 6818.472) / 36515.294
=-0.013777

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Tauns Laboratories has a M-score of -3.10 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -3.10 mean?
Tauns Laboratories (TSE:197A) has a Beneish M-Score of -3.10 as of Jul. 18, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Tauns Laboratories and its competitors. According to the industry distribution chart, Tauns Laboratories ranks #149 out of 763 companies in the Medical Devices & Instruments industry, placing it in the top 19.5%.
Is Tauns Laboratories' Beneish M-Score too high?
Tauns Laboratories' current Beneish M-Score is -3.10. Based on the distribution chart, Tauns Laboratories ranks #149 out of 763 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Tauns Laboratories has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Tauns Laboratories' Beneish M-Score compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Tauns Laboratories ranks #149 out of 763 companies for Beneish M-Score. This places Tauns Laboratories in the top 20% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Devices & Instruments company?
A good Beneish M-Score depends on the Medical Devices & Instruments industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Tauns Laboratories and its competitors. Tauns Laboratories's current Beneish M-Score is -3.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tauns Laboratories stock overvalued right now?
Tauns Laboratories (TSE:197A) has a current Beneish M-Score of -3.10. The current Beneish M-Score is -3.10. Tauns Laboratories' overall GF Score™ is 14/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Tauns Laboratories (TSE:197A), the current Beneish M-Score is -3.10 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Tauns Laboratories Business Description

Address 761-1 Kamishima Izunokuni-shi, Shizuoka, JPN, 410-2325
Tauns Laboratories Inc is engaged in development, manufacture and sales of in vitro diagnostics and research reagents. Its product include Capilia Flu Neo, Capilia Adeno Neo, Capilia RSV Neo, Capilia hMPV, etc.
14GF Score

Get the complete analysis for TSE:197A

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円484.00
Price